申请人:John Wyeth and Brother Ltd.
公开号:US04783455A1
公开(公告)日:1988-11-08
Compounds of formula (I) ##STR1## and their pharmaceutically acceptable acid addition salts, wherein R represents lower alkyl or a mono- or bicyclic aryl or heteroaryl radical, R.sup.1 and R.sup.2 which may be the same or different each represent hydrogen, hydroxyl, lower alkyl, lower alkoxy, halo(lower)alkyl, halogen, amino or mono- or di(lower)alkylamino, X represents--CH.sub.2 CR.sup.3 R.sup.4 CH.sub.2 --or --(CH.sub.2).sub.4 --where R.sup.3 and R.sup.4 each independently represent hydrogen or lower alkyl or R.sup.3 and R.sup.4 together with the carbon atom to which they are attached represent a 5, 6 or 7 membered carbocyclic ring and R.sup.5 represents acyl and R.sup.6 represents hydrogen or R.sup.5 and R.sup.6 each independently represent hydrogen or lower alkyl, are useful as hypoglycaemics.
式(I)的化合物及其药学上可接受的酸加盐,其中R代表较低的烷基或单环或双环芳基或杂环芳基基团,R.sup.1和R.sup.2可以相同也可以不同,分别代表氢、羟基、较低的烷基、较低的烷氧基、卤素(较低)烷基、卤素、氨基或单或二(较低)烷基氨基,X代表--CH.sub.2 CR.sup.3 R.sup.4 CH.sub.2 --或--(CH.sub.2).sub.4--,其中R.sup.3和R.sup.4各自独立地代表氢或较低烷基或R.sup.3和R.sup.4与它们连接的碳原子一起代表一个5、6或7成员的碳环,R.sup.5代表酰基,R.sup.6代表氢或R.sup.5和R.sup.6各自独立地代表氢或较低烷基,用作降血糖剂。